[1] Easton DF, Pooley KA, Dunning AM, et al.Genome-wide association study identifies novel breast cancer susceptibility loci[J]. Nature, 2007, 447(7148):1087-1093. [2] Stacey SN, Manolescu A, Sulem P, et al.Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer[J]. Nat Genet, 2007, 39(7):865-869. [3] Ruiz-Narváez EA, Rosenberg L, Cozier YC, et al.Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(5):1320-1327. [4] Liang J, Chen P, Hu Z, et al.Genetic variants in trinucleotide repeat-containing 9(TNRC9)are associated with risk of estrogen receptor positive breast cancer in a Chinese population[J]. Breast Cancer Res Treat, 2010, 124(1):237-241. [5] Chen MB, Wu XY, Shen W, et al.Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk:evidence from 62, 005 subjects[J]. Breast Cancer Res Treat, 2011, 126(1):177-183. [6] Han W, Woo JH, Yu JH, et al.Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20(5):793-798. [7] Elematore I, Gonzalez-Hormazabal P, Reyes JM, et al.Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population[J]. Mol Biol Rep, 2014, 41(6):3715-3722. [8] Long J, Cai Q, Shu, et al. Identification of a functional genetic variant at 16q12. 1 for breast cancer risk:Results from the Asia Breast Cancer Consortium[J]. PLoS Genet, 2010, 6(6):e1001002. [9] He X, Yao G, Li F, et al.Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China[J]. Int J Mol Sci, 2014, 15(2):2130-2141. [10] Liao J, Chen Y, Zhu J, et al.Polymorphisms in the TOX3/LOC643714 and risk of breast cancer in south China[J]. Int J Biol Markers, 2018, 4(1):1-8. [11] Zhang B, Chen MY, Shen YJ, et al.A large-scale, exome-wide association study of han chinese women identifies three novel loci predisposing to breast cancer[J]. Cancer Res, 2018, 78(11):3087-3097. [12] Hsieh YC, Tu SH, Su CT, et al.A polygenic risk score for breast cancer risk in a Taiwanese population[J]. Breast Cancer Res Treat, 2017, 163(1):131-138. [13] Al-Eitan, Laith N, Jamous, et al. Candidate gene analysis of breast cancer in the jordanian population of arab descent:A case-control study[J]. Cancer Invest, 2017, 35(4):256-270. [14] Palomba G, Loi A, Porcu E, et al.Genome-wide association study of susceptibility loci for breast cancer in Sardinian population[J]. BMC Cancer, 2015, 15:383-392. [15] Garcia-Closas M, Chanock S.Genetic susceptibility loci for breast cancer by estrogen receptor status[J]. Clin Cancer Res, 2008, 14(24):8000-8009. [16] Guo JZ, Sueta A, Nakamura K, et al.Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre-and postmenopausal Japanese women[J]. Oncotarget, 2017, 8(39):65759-65769. [17] Han CC, Yue LL, Yang Y, et al.TOX3 protein expression is correlated with pathological characteristics in breast cancer[J]. Oncology Letters, 2016, 11:1762-1768. [18] Gudmundsdottir ET, Barkardottir RB, Arason A, et al.The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients[J]. BMC Cancer, 2012, 12:621-630. [19] Smid M, Wang Y, Klijn JG, et al.Genes associated with breast cancer metastatic to bone[J]. J Clin Oncol, 2006, 24(15):2261-2267. [20] Shan J, Dsouza SP, Bakhru S, et al.TNRC9 down-regulates BRCA1 expression and promotes breast cancer aggressiveness[J]. Cancer Res, 2013, 73(9):2840-2849. [21] Easton DF, Pooley KA, Dunning AM, et al.Genome-wide association study identifies novel breast cancer susceptibility loci[J]. Nature, 2007, 447(7148):1087-1093. [22] 韩翠翠, 岳丽玲, 杨莹, 等. 稳定过表达TOX3的乳腺癌MDA-MB-231细胞系的建立[J]. 细胞与分子免疫学杂志, 2014, 30(11):1154-1158. [23] 温宪春, 韩翠翠, 赵月生, 等. FUT8基因RNAi慢病毒载体的构建及对MCF-7细胞增殖的影响[J]. 生物技术通报, 2015, 31(5):231-236. |